2005 Post 200
Dialysis Corporation of America
1302 Concourse Dr.
Linthicum, Md. 21076
www.dialysiscorporation.com
Industry: health care
Post 200 Category: Top 125 Companies
Revenue: $40.99 Million
Net Income/Loss: $2.21 Million
Earnings per share: $0.25
Dividend: n/a
Stockholder equity: $13.33 Million
Auditor: Moore Stephens PC
Stock: DCAI
Assets: $26.49 Million
Market capitalization: $144.77 Million
52-week high: 35 3/2/2005
52-week low: 3.75 6/1/2004
President and CEO: Stephen W. Everett
VP, Operations: Michael Rowe
Employees: 301
Local employees: 47
Description: The company owns kidney dialysis centers in Virginia, Georgia, Maryland, New Jersey, Ohio, Pennsylvania and South Carolina. DCA also provides dialysis in hospitals on a contract basis. It owns 23 dialysis centers and operates two others.
Developments: Continuing its rapid expansion of recent years, the company extended its reach by buying or building a flurry of dialysis centers in 2004. The expansion reflected the growing need of an aging population for outpatient dialysis to treat chronic kidney failure and other kidney diseases. In February, the company opened a facility in Warsaw, its first center in Virginia, as part of its expansion in the mid-Atlantic region. A month later, DCA opened a dialysis center in Aiken, S.C., its first in the state. That was followed by the opening of a facility in Pottstown, Pa., its sixth in the state. In June, the company announced the development of a center in Ashland, its second in Virginia. Also that month, DCA announced the opening of a center in Rockville, its second in Maryland. The company bought two facilities in Pennsylvania in September and announced the development of another in Cincinnati in October in conjunction with the University of Cincinnati's College of Medicine. The company kicked off 2005 much the same way, announcing in January that three more facilities are under development in South Carolina. The company has funded its growth in part through its own cash flow as well as from financing from its parent company, Medicore Inc. of Hialeah, Fla., which owns 57 percent of DCA. The construction of a facility costs up to about $1 million, and acquiring an existing center can be more expensive. In March, DCA announced that it would buy its parent company in a stock deal valued at about $152 million.